EVE Health GroupASX:EVE EV-to-FCF is -3.76 as of Jul. 03, 2026. The stock has 6 warning signs investors should review. Among 1,190 Consumer Packaged Goods companies, EVE Health Group ranks worse than 84033.53% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, EVE Health Group's Enterprise Value is A$5.80 Mil.
EVE Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.54 Mil. Therefore, EVE Health Group's EV-to-FCF for today is -3.76.
The historical rank and industry rank for EVE Health Group's EV-to-FCF or its related term are showing as below:
ASX:EVE'
s EV-to-FCF Range Over the Past 10 Years
Min: -14.93 Med: -3.69 Max: -0.67
Current: -3.76
During the past 13 years, the highest EV-to-FCF of EVE Health Group was -0.67. The lowest was -14.93. And the median was -3.69.
ASX:EVE's EV-to-FCF is ranked worse than 100% of 1190
companies
in the Consumer Packaged Goods industry
Industry Median: 15.405
vs ASX:EVE: -3.76
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EVE Health Group's PE Ratio (TTM) for today is calculated as:
EVE Health Group's share price for today is A$0.019.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EVE Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.007.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
EVE Health Group EV-to-FCF Related Terms
EVE Health Group EV-to-FCF Historical Data
* Premium members only.
The historical data trend for EVE Health Group's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, EVE Health Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EVE Health Group EV-to-FCF vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, EVE Health Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where EVE Health Group's EV-to-FCF falls into.
EVE Health Group's current Enterprise Value is A$5.80 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EVE Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-1.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EVE Health Group (ASX:EVE) has a EV-to-FCF of -3.76 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on EVE Health Group and its competitors. According to the industry distribution chart, EVE Health Group ranks #999999 out of 1190 companies in the Consumer Packaged Goods industry.
Is EVE Health Group's EV-to-FCF too high?
EVE Health Group's current EV-to-FCF is -3.76. Based on the distribution chart, EVE Health Group ranks #999999 out of 1190 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does EVE Health Group's EV-to-FCF compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, EVE Health Group ranks #999999 out of 1190 companies for EV-to-FCF. This places EVE Health Group in the lower half of its industry. The industry median EV-to-FCF is 15.41. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Consumer Packaged Goods company?
The median EV-to-FCF among Consumer Packaged Goods companies is 15.41, based on 1,190 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on EVE Health Group and its competitors. For the Consumer Packaged Goods industry, the median EV-to-FCF is 15.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVE Health Group's current EV-to-FCF is -3.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 90% above its estimated fair value. The current EV-to-FCF is -3.76. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current EV-to-FCF is -3.76 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EVE has been successfully added to your 